Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-structural maintenance of chromosomes element 3 homolog, abbreviated as NSMCE3, is a protein component of the SMC5-SMC6 chromatin organizing complex and belongs to the MAGE superfamily[3][4][7][8]. The SMC5-SMC6 complex is essential for DNA double-strand break repair by homologous recombination, contributing to genome stability, chromosome segregation, and telomere maintenance, especially via the ALT (alternative lengthening of telomeres) pathway[1][3][8]. NSMCE3 modulates sumoylation activities (particularly of shelterin complex proteins), influences ubiquitin ligase activity, and may function as a growth suppressor by facilitating cell cycle arrest[1][3][8]. Pathogenic mutations in NSMCE3 are known to cause syndromes characterized by immunodeficiency and chromosome instability, and dysregulation may contribute to cancer development, especially those associated with telomere maintenance defects[3][6][7]. No drugs directly target NSMCE3, and it is not currently considered a therapeutic target, but its function is central to pathways critical for DNA repair and genome maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-structural maintenance of chromosomes element 3 homolog (NSMCE3).